Skip to Main Content
Home Books Greenspan’s Basic & Clinical Endocrinology, 9e

Chapter 17. Pancreatic Hormones and Diabetes Mellitus

Umesh Masharani, MB, BS, MRCP (UK); Michael S. German, MD

  • Sections
  • Print
  • Get Citation

    Citation

    AMA Citation
    Masharani U, German MS. Masharani U, German M.S. Masharani, Umesh, and Michael S. German.Chapter 17. Pancreatic Hormones and Diabetes Mellitus. In: Gardner DG, Shoback D. Gardner D.G., Shoback D Eds. David G. Gardner, and Dolores Shoback.eds. Greenspan’s Basic & Clinical Endocrinology, 9e New York, NY: McGraw-Hill; 2011. http://accessmedicine.mhmedical.com/content.aspx?bookid=380&sectionid=39744057. Accessed February 16, 2019.
    MLA Citation
    Masharani U, German MS. Masharani U, German M.S. Masharani, Umesh, and Michael S. German.. "Chapter 17. Pancreatic Hormones and Diabetes Mellitus." Greenspan’s Basic & Clinical Endocrinology, 9e Gardner DG, Shoback D. Gardner D.G., Shoback D Eds. David G. Gardner, and Dolores Shoback. New York, NY: McGraw-Hill, 2011, http://accessmedicine.mhmedical.com/content.aspx?bookid=380&sectionid=39744057.

    Download citation file:

    RIS (Zotero)
    EndNote
    BibTex
    Medlars
    ProCite
    RefWorks
    Reference Manager
    Mendeley
    © Copyright
  • Tools
  • Search Book
  • Clip
Top

  • ABCC8 ATP-binding cassette transporter sub-family C member 8
  • ACE Angiotensin-converting enzyme
  • ADA American Diabetes Association
  • ADH Antidiuretic hormone (vasopressin)
  • AGE Advanced glycation end product
  • AGPAT 1-acylglycerol-3-phosphate-O-acyltransferase 2
  • AKT/PKB AKR mouse tumor 8 kinase/protein kinase B
  • AIRE Autoimmune regulator
  • ALT Alanine aminotransferase
  • AMPK Adenosine monophosphate-activated protein kinase
  • APS1 Autoimmune polyendocrinopathy syndrome type 1
  • ATF6 Activating transcription factor 6
  • BMIy Body mass index
  • cAMP Cyclic adenosine monophosphate
  • CCK Cholecystokinin
  • CEL Carboxyl-ester lipase
  • cGMP Cyclic 3′,5′-guanosine monophosphate
  • CIDEC Cell death-inducing DFFA-like effector C
  • CSII Continuous subcutaneous insulin infusion
  • CST Contraction stress test
  • DCCT Diabetes Control and Complications Trial
  • DIDMOAD Diabetes insipidus, diabetes mellitus, optic atrophy, deafness (Wolfram syndrome)
  • DPP Diabetes Prevention Program
  • DPP-4 Dipeptidyl peptidase 4
  • DPT-1 Diabetes Prevention Trial-1
  • EIF2AK3 Eukaryotic translation initiation factor 2-α kinase 3
  • ER Endoplasmic reticulum
  • FDA Food and Drug Administration
  • FFA Free fatty acid
  • FHR Fetal heart rate
  • Foxo1 Forkhead box, subfamily O, member 1
  • FOXP3 Forkhead box, subfamily P, member 3
  • GABA Gamma-aminobutyric acid
  • GAD Glutamic acid decarboxylase
  • GCK Glucokinase
  • GH Growth hormone
  • GHb Glycohemoglobin
  • GHSR Growth hormone-secretagogue receptor
  • GI Glycemic index
  • GIP Gastric inhibitory polypeptide
  • GLIS3 Glioma-associated oncogene homolog—similar 3
  • GLP-1 Glucagon-like peptide-1
  • GLP-2 Glucagon-like peptide-2
  • GLUT Glucose transporter
  • GPCR G protein-coupled receptor
  • GRPP Glicentin-related polypeptide
  • GWAS Genome-wide association study
  • HDL High-density lipoprotein
  • HLA Human leukocyte antigen
  • HNF Hepatocyte nuclear factor
  • hPL Human placental lactogen
  • IA2 Insulinoma antigen 2
  • IAA Insulin autoantibody
  • IAPP Islet amyloid polypeptide
  • ICA Islet cell antibody
  • IFG Impaired fasting glucose
  • IGF-1 Insulin-like growth factor 1
  • IGT Impaired glucose tolerance
  • IL-6 Interleukin-6
  • INS Insulin
  • IP3 Inositol 1,4,5-triphosphate
  • IPEX Immunodysregulation polyendocrinopathy enteropathy, X-linked
  • IPF-1 Insulin promoter factor-1
  • IRE1 Inositol-requiring enzyme 1
  • IRS Insulin receptor substrate
  • ISL1 Islet transcription factor 1
  • IUGR Intrauterine growth restriction
  • KPD Ketosis prone diabetes
  • KCNJ11 Potassium inwardly-rectifying channel, subfamily J, member 11
  • Kir6.2 Potassium channel, inwardly- rectifying 6.2
  • LADA Latent autoimmune diabetes of adulthood
  • LBK1 Liver kinase B1
  • LDL Low-density lipoprotein
  • MAPK Mitogen-activated protein kinase
  • MODY Maturity-onset diabetes of the young
  • MHC Major histocompatibility complex
  • mTOR Mammalian target of rapamycin
  • NeuroD1 Neural differentiation factor 1
  • Neurog3 Neural genesis factor 3
  • NIH National Institutes of Health
  • NPH Neutral protamine hagedorn
  • NST Nonstress test
  • PAI-1 Plasminogen activator inhibitor-1
  • PAX4 Paired homeobox 4
  • PCSK Proprotein convertase, subtilisin/kexin
  • PDE5 Phosphodiesterase type 5
  • PDX1 Pancreatic duodenal homeobox-1
  • PERK Protein kinase R-like endoplasmic reticulum kinase
  • PGC1α PPAR gamma coactivator-1α
  • PNDM Permanent neonatal diabetes mellitus
  • POEMS Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes
  • PP Pancreatic polypeptide
  • PPAR Peroxisome proliferator-activated receptor
  • PTF1A Pancreatic transcription factor 1α
  • PTP1b Protein tyrosine phosphatase 1b
  • RFX6 Regulatory factor X-6
  • RXR 9-cis-retinoic acid receptor
  • SCL19A2 Solute carrier family 19 (thiamine transporter), member 2
  • SOCS Suppressor of cytokine signaling
  • SREBP1c Sterol regulatory element-binding protein 1c
  • SSTR Somatostatin receptor
  • SUR1 Sulfonylurea receptor 1
  • TCF7L2 Transcription factor 7-like 2
  • TGF-a Transforming growth factor-β
  • TNDM Transient neonatal diabetes mellitus
  • TNF-α Tumor necrosis factor-α
  • UGDP University Group Diabetes Program
  • UKPDS United Kingdom Prospective Diabetes Study
  • VEGF Vascular endothelial growth factor
  • VLDL Very low ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MHE Privacy Center Close